Chloe Orkin

机构：Queen Mary University of London, Barts Health NHS Trust · ORCID：0000-0001-6168-6745

发表论文 332 篇 · 总被引 17934 次 · h-index 64

代表论文

• Macrophage-augmented organoids recapitulate the complex pathophysiology of viral diseases and enable development of multitarget therapeutics (2025 · Nature Biomedical Engineering · 被引 17)
• Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV (2025 · HIV Medicine · 被引 14)
• Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process (2025 · The Lancet HIV · 被引 10)
• Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions (2025 · Open Forum Infectious Diseases · 被引 10)
• Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial (2025 · medRxiv · 被引 8)
• Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks (2025 · Viruses · 被引 7)